These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 6319518

  • 21. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB, Harden TK.
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [Abstract] [Full Text] [Related]

  • 22. Regulation of adenylate cyclase coupled beta-adrenergic receptors by beta-adrenergic catecholamines.
    Mukherjee C, Caron MG, Lefkowitz RJ.
    Endocrinology; 1976 Aug; 99(2):347-57. PubMed ID: 954636
    [Abstract] [Full Text] [Related]

  • 23. Regulation of beta-agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells.
    Penn RB, Kelsen SG, Benovic JL.
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):496-505. PubMed ID: 7917318
    [Abstract] [Full Text] [Related]

  • 24. Decreased neutrophil beta adrenergic receptors in the neonate.
    Roan Y, Galant SP.
    Pediatr Res; 1982 Aug; 16(8):591-3. PubMed ID: 6287401
    [Abstract] [Full Text] [Related]

  • 25. [Desensitization of beta-adrenoreceptors and its influence on manifestations of the antiradiation effect of isoproterenol].
    Chirkov IuIu, Malatsidze MA, Kazarov AR, Blashkin IuV, Sobolev AS.
    Biull Eksp Biol Med; 1984 Nov; 98(11):558-60. PubMed ID: 6095944
    [Abstract] [Full Text] [Related]

  • 26. Homologous desensitization of rat heart cells to beta-adrenergic stimulation and the absence of alpha-adrenergic or prostaglandin E1 effects.
    Fisher RA, Harary I, Thomas JA.
    J Cyclic Nucleotide Protein Phosphor Res; 1984 Nov; 9(6):449-60. PubMed ID: 6151955
    [Abstract] [Full Text] [Related]

  • 27. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY, Hom DS, Loh HH.
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [Abstract] [Full Text] [Related]

  • 28. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG, Sylvestre D, Homcy CJ.
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [Abstract] [Full Text] [Related]

  • 29. [Mechanisms of desensitization of beta-adrenergic receptors].
    Cros G.
    Bull Eur Physiopathol Respir; 1985 Oct; 21(5):35s-43s. PubMed ID: 2865991
    [Abstract] [Full Text] [Related]

  • 30. Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes.
    Nakada MT, Stadel JM, Poksay KS, Crooke ST.
    Mol Pharmacol; 1987 Apr; 31(4):377-84. PubMed ID: 3033466
    [Abstract] [Full Text] [Related]

  • 31. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors.
    Pittman RN, Reynolds EE, Molinoff PB.
    J Pharmacol Exp Ther; 1984 Sep; 230(3):614-8. PubMed ID: 6147404
    [Abstract] [Full Text] [Related]

  • 32. Regulation of adenosine 3':5'-monophosphate content of human astrocytoma cells: mechanism of agonist-specific desensitization.
    Su YF, Johnson GL, Cubeddu L, Leichtling BH, Ortmann R, Perkins JP.
    J Cyclic Nucleotide Res; 1984 Sep; 2(4):271-85. PubMed ID: 184126
    [Abstract] [Full Text] [Related]

  • 33. Studies on desensitization of adrenergic receptors of human adipocytes.
    Burns TW, Langley PE, Terry BE, Bylund DB.
    Metabolism; 1982 Mar; 31(3):288-93. PubMed ID: 6281616
    [Abstract] [Full Text] [Related]

  • 34. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
    Nantel F, Bonin H, Emorine LJ, Zilberfarb V, Strosberg AD, Bouvier M, Marullo S.
    Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307
    [Abstract] [Full Text] [Related]

  • 35. Ontogeny of cardiac beta-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling.
    Zeiders JL, Seidler FJ, Iaccarino G, Koch WJ, Slotkin TA.
    J Mol Cell Cardiol; 1999 Feb; 31(2):413-23. PubMed ID: 10093053
    [Abstract] [Full Text] [Related]

  • 36. Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
    Sawutz DG, Kalinyak K, Whitsett JA, Johnson CL.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):1-7. PubMed ID: 6208354
    [Abstract] [Full Text] [Related]

  • 37. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K, Pedone C, Brooker G.
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [Abstract] [Full Text] [Related]

  • 38. Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex.
    Dibner MD, Molinoff PB.
    J Pharmacol Exp Ther; 1979 Sep; 210(3):433-9. PubMed ID: 39161
    [Abstract] [Full Text] [Related]

  • 39. Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes.
    Chan SC, Grewe SR, Stevens SR, Hanifin JM.
    J Cyclic Nucleotide Res; 1982 Sep; 8(4):211-24. PubMed ID: 6300207
    [Abstract] [Full Text] [Related]

  • 40. Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats.
    Chang HY, Klein RM, Kunos G.
    J Pharmacol Exp Ther; 1982 Jun; 221(3):784-9. PubMed ID: 6283064
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.